KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Net Income (2016 - 2025)

Opko Health's Net Income history spans 16 years, with the latest figure at -$46.2 million for Q4 2025.

  • For Q4 2025, Net Income changed N/A year-over-year to -$46.2 million; the TTM value through Dec 2025 reached -$240.6 million, down 257.88%, while the annual FY2025 figure was -$240.6 million, 352.3% down from the prior year.
  • Net Income reached -$46.2 million in Q4 2025 per OPK's latest filing, down from $21.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $31.1 million in Q1 2021 to a low of -$148.4 million in Q2 2025.
  • Average Net Income over 5 years is -$44.9 million, with a median of -$55.4 million recorded in 2022.
  • Peak YoY movement for Net Income: soared 152.75% in 2021, then tumbled 1340.62% in 2025.
  • A 5-year view of Net Income shows it stood at -$73.3 million in 2021, then fell by 16.23% to -$85.2 million in 2022, then rose by 22.16% to -$66.3 million in 2023, then skyrocketed by 137.53% to $24.9 million in 2024, then plummeted by 285.75% to -$46.2 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Net Income are -$46.2 million (Q4 2025), $21.6 million (Q3 2025), and -$148.4 million (Q2 2025).